Fig. 3

Evolution of VEGF plasma levels of the different patients (P1-P7) at the different visits during the clinical trial. Arrows indicate three cases wherein VEGF levels were initially greater than the normal threshold, and the decrease was significant, reaching normal levels following propranolol treatment